Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 2 open reading frame 49 (C2orf49), also known as Ashwin, is a protein-coding gene in humans belonging to the ashwin family. Its protein product has no well-characterized function but is predicted to be part of the tRNA-splicing ligase complex, suggesting a role in tRNA processing and possibly RNA metabolism. Experimental data in Xenopus (frog) orthologs indicate that Ashwin is implicated in cell survival during neural development and in patterning of the embryo, with effects on apoptosis and tissue specification. In humans, it is localized to the nucleoplasm and associated (via datasets and interaction predictions) with RNA processing pathways. There is a weak disease association reported with aggressive systemic mastocytosis, but no established role as a therapeutic target, biomarker, or drug-interacting molecule[1][2][3][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 2 open reading frame 49 (C2orf49).